[Cardiovascular effects of 2,5-dimethoxy-4-methyl amphetamine (S.T.P. or D.O.M.)].
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D006213:Hallucinogens / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D006213:Hallucinogens; D010643:Phenoxybenzamine; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; D012110:Reserpine; D000661:Amphetamine; D003042:Cocaine
Actions cardiovasculaires de la diméthoxy-2, 5 méthyl-4 amphétamine (S.T.P. ou D.O.M.